NextCure effects 1:12 reverse stock split effective July 14, 2025

NextCure, Inc.

Reverse stock split ratio 1:12, effective 12:01 a.m. ET on July 14, 2025.
Stockholders approved split ratio range of 1:5 to 1:15; Board chose 1:12.
No fractional shares; cash payment for fractional shares based on closing price prior to effective date.
Authorized shares remain 100 million; all outstanding options, warrants, and equity plans adjusted proportionally.
Common stock continues trading under ticker NXTC on Nasdaq Global Select Market.

item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.